Stoke Therapeutics, Inc. (STOK)
32.78
+0.04
(+0.12%)
USD |
NASDAQ |
Apr 06, 16:00
32.78
0.00 (0.00%)
After-Hours: 18:07
Stoke Therapeutics SG&A Expense (TTM) : 67.09M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| Krystal Biotech, Inc. | 146.91M |
| Scholar Rock Holding Corp. | 176.20M |
| Vertex Pharmaceuticals, Inc. | 1.753B |
| Zymeworks, Inc. | 61.51M |